Genomic imbalances in CML blast crisis: 8q24.12-q24.13 segment identified as a common region of over-representation

Genes Chromosomes and Cancer

Volumn 37, Issue 4, 2003, Pages 346-358

  Gribble, Susan M ^a,c   Reid, Alistair G ^a,d   Roberts, Ian ^a   Grace, Colin ^b   Green, Anthony R ^a   Nacheva, Elizabeth P ^a,d  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b Digital Scientific Ltd   (United Kingdom)

^c WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^d ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AMPLICON; ARTICLE; BLAST CELL CRISIS; CHROMOSOME 13Q; CHROMOSOME 6; CHROMOSOME 8Q; CHROMOSOME 9; CHROMOSOME ABERRATION; CHROMOSOME G BAND; CHROMOSOME PAINTING; CHRONIC MYELOID LEUKEMIA; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; KARYOTYPE; LEUKEMIA CELL LINE; MALE; MARKER CHROMOSOME; MARKER GENE; PRESCHOOL CHILD; PRIORITY JOURNAL;

ALLELIC IMBALANCE; BLAST CRISIS; CHROMOSOME ABERRATIONS; CHROMOSOME PAINTING; CHROMOSOMES, HUMAN, PAIR 8; GENE AMPLIFICATION; GENE REARRANGEMENT; GENETIC MARKERS; GENOME, HUMAN; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; K562 CELLS; KARYOTYPING; LEUKEMIA, MYELOID, CHRONIC; NUCLEIC ACID HYBRIDIZATION; TUMOR CELLS, CULTURED;

EID: 0038799721     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.10173     Document Type: Article

References (43)

1. Albertson DG, Yistra B, Segraves R, Collins C, Dairkee SH, Kowbel D, Kuo W-L, Gray JW, Pinkel D. 2000. Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. Nat Genet 25:144-146.
2. Avet-Loiseau H, Andree-Ashley LE, Moore D, Mellerin MP, Feusner J, Bataille R, Pallavicini MG. 1997. Molecular cytogenetic abnormalities in multiple myeloma and plasma cell leukemia measured using comparative genomic hybridization. Genes Chromosomes Cancer 19:124-133.
3. Boultwood J, Fidler C, Shepherd P, Watkins F, Snowball J, Haynes S, Kusec R, Gaiger A, Littlewood TJ, Peniket AJ, Wainscoat JS. 1999. Telomere length shortening is associated with disease evolution in chronic myelogenous leukemia. Am J Hematol 61:5-9.
4. Bruch J, Wohr G, Hautmann R, Mattfeldt T, Bruderlein S, Moller P, Sauter S, Hameister H, Vogel W, Paiss T. 1998. Chromosomal changes during progression of transitional cell carcinoma of the bladder and delineation of the amplified interval on chromosome arm 8q. Genes Chromosomes Cancer 23:167-174.
5. Brummendorf TH, Holyoak TL, Rufer N, Barnett MJ, Schulzer M, Eaves CJ, Eaves AC, Lansdorp PM. 2000. Prognostic implications of differences in telomere length between normal and malignant cells from patients with chronic myeloid leukemia measured by flow cytometry. Blood 95:1883-1890.
6. Coleman AE, Schrock E, Weaver Z, du Manoir S, Yang F, Ferguson-Smith MA, Ried T, Janz S. 1997. Previously hidden chromosome aberrations in t(12;15)-positive BALB/c plasmacytomas uncovered by multicolor spectral karyotyping. Cancer Res 57:4585-4592.
7. Drexler HG, MacLeod RA, Uphoff CC. 1999. Leukemia cell lines: in vitro models for the study of Philadelphia chromosome-positive leukemia. Leuk Res 23:207-215.
8. Forozan F, Karhu R, Kononen J, Kallioniemi A, Kallioniemi OP. 1997. Genome screening by comparative genomic hybridization. Trends Genet 13:405-409.
9. Gribble SM, Sinclair PB, Grace C, Green AR, Nacheva EP. 1999. Comparative analysis of G-banding, chromosome painting, locus-specific fluorescence in situ hybridization, and comparative genomic hybridization in chronic myeloid leukemia blast crisis. Cancer Genet Cytogenet 111:7-17.
10. Gribble SM, Roberts I, Grace C, Andrews KM, Green AR, Nacheva EP. 2000. Cytogenetics of the chronic myeloid derived-derived cell line K562: karyotype clarification by multicolor fluorescence in situ hybridization, comparative genomic hybridization, and locus-specific fluorescence in situ hybridization. Cancer Genet Cytogenet 118:1-8.
11. Heisterkamp N, Stephenson JR, Groffen J, Hansen PF, de Klein A, Bartram CR, Grosveld G. 1983. Localization of the c-ab1 oncogene adjacent to a translocation break point in chronic myelocytic leukemia. Nature 306:239-242.
12. Huntly B, Reid AG, Bench AJ, Campbell LJ, Telford N, Shepherd P, Szer J, Prince HM, Turner P, Grace C, Nacheva EP, Green AR. 2001. Deletions of the derivative chromosome 9 occur at the time of the Philadelphia translocation and provide a powerful and independent prognostic indicator in chronic myeloid leukemia. Blood 98:1732-1738.
13. Iwabushi H, Sakamoto M, Sakunaga H, Ma YY, Carcangiu ML, Pinkel D, Yang-Feng TL, Gray JW. 1995. Genetic analysis of benign, low grade, and high grade ovarian tumors. Cancer Res 55:6172-6180.
14. Jahal SM, Law ME, Stamberg J, Fonseca R, Seely JR, Myers WH, Hanson CA. 2001. Detection of diagnostically critical, often hidden, anomalies in complex karyotypes of haematological disorders using multicolor fluorescence in situ hybridization. Br J Haematol 112:975-980.
15. Kallioniemi OP, Kallioniemi A, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D. 1993. Comparative genomic hybridization: a rapid new method for detecting and mapping DNA amplification in tumors. Semin Cancer Biol 4:41.
16. Keating A. 1987. Ph positive CML cell lines. Baillieres Clin Haematol 1:1021-1029.
17. Kishi K. 1985. A new leukemia cell line with Philadelphia chromosome characterized as basophil precursors. Leuk Res 9:381-390.
18. Kolomietz E, Al-Maghrabi J, Brennan S, Karaskova J, Minkin S, Lipton J, Squire JA. 2001. Primary chromosomal rearrangements of leukemia are frequently accompanied by extensive sub-microscopic deletions and may lead to altered prognosis. Blood 97:3581-3588.
19. Kuriyama K, Gale RP, Tomonaga M, Ikeda S, Yao E, Klisak I, Whelan K, Yakir H, Ichimaru M, Sparkes RS, Dreazen O. 1989. CML-T1: a cell line derived from T-lymphocyte acute phase of chronic myelogenous leukemia. Blood 74:1381-1387.
20. Kytola S, Rummukainen J, Nordgren A, Karhu R, Farnebo F, Isola J, Larson C. 2000. Chromosomal alterations in 15 breast cancer cell lines by comparative genomic hybridization and spectral karyotyping. Genes Chromosomes Cancer 28:308-317.
21. Lozzio CB, Lozzio BB. 1975. Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood 45:321-334.
22. Mitelman F, Johansson B, Mertens F, editors. 2003. Mitelman database of chromosome aberrations in cancer. May be accessed at http://cgap.nci.nih.gov/Chromosomes/Mitelman
23. Nacheva E, Kearney L, Young B. 1993. In situ hybridization analysis of a homogeneously staining region at 11q23-24 in an acute myeloid leukemia (M5) using yeast artificial chromosomes. Genes Chromosomes Cancer 7:23-27.
24. Nacheva EP, Gribble S, Andrews K, Wienberg J, Grace C. 2000. Screening for specific chromosome involvement in hematological malignancies using a set of seven chromosome painting probes. An alternative approach for chromosome analysis using standard FISH instrumentation. Cancer Genet Cytogenet 122:65-72.
25. Nupponen NN, Isola J, Visakorpi T. 2000. Mapping the amplification of EIF3S3 in breast and prostate cancer. Genes Chromosomes Cancer 28:203-210.
26. Ogura M, Morishima Y, Ohno R, Kato Y, Hirabayashi N, Nagura H, Saito H. 1985. Establishment of a novel human megakaryoblastic leukemia cell line, MEG-01, with positive Philadelphia chromosome. Blood 66:1384-1392.
27. Ohkubo T, Kamamoto T, Kita K, Hiraoka A, Yoshida Y, Uchino H. 1985. A novel Ph1 chromosome positive cell line established from a patient with chronic myelogenous leukemia in blastic crisis. Leuk Res 9:921-926.
28. Okabe M, Kunieda Y, Nakane S, Kurosawa M, Itaya T, Vogler WR, Shoji M, Miyazaki T. 1995. Establishment and characterization of a new Ph1-positive chronic myeloid leukemia cell line MC3 with trilineage phenotype and an altered p53 gene. Leuk Lymphoma 16:493-503.
29. Okuno Y, Suzuki A, Ichiba S, Takahashi T, Nakamura K, Hitomi K, Sasaki R, Tada K, Imura H. 1990. Establishment of an erythroid cell line (JK-1) that spontaneously differentiates to red cells. Cancer 66:1344-1551.
30. Paszek-Vigier M, Talmant P, Mechinaud F, Garand R, Harousseau JL, Bataille R, Avet-Loiseau H. 1997. Comparative genomic hybridization is a powerful tool, complementary to cytogenetics, to identify chromosomal abnormalities in childhood acute lymphoblastic leukemia. Br J Haematol 99:589-596.
31. Pegoraro L, Matera L, Ritz J, Levis A, Palumbo A, Biagini G. 1983. Establishment of a Ph1-positive human cell line (BV173). J Natl Cancer Inst 70:447-453.
32. Rao PH, Cigudosa JC, Ning Y, Calasanz MJ, Iida S, Tagawa S, Michaeli J, Klein B, Dalla-Favera R, Jhanwar SC, Ried T, Chaganti RS. 1998. Multicolor spectral karyotyping identifies new recurring breakpoints and translocations in multiple myeloma. Blood 92:1743-1748.
33. Raskind WH, Disteche CM, Keating A, Singer JW. 1987. Correlation between cytogenetic and molecular findings in human chronic myelogenous leukemia lines EM-2 and EM-3. Cancer Genet Cytogenet 25:271-284.
34. Reid A, Gribble SM, Andrews KM, Green AR, Nacheva EP. 2001. Chromosome band specific FISH probes allow improved detection of terminal translocations in leukemic metaphases. Leukemia 15:860-861.
35. Ried T, Knutzen R, Steinbeck R, Blegen H, Schrock E, Heselmeyer K, du Manoir S, Auer G. 1996. Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors. Genes Chromosomes Cancer 15:234-245.
36. Roberts I, Wienberg J, Nacheva E, Grace C, Griffin D, Coleman N. 1999. Novel method for the production of multiple color chromosome paints for use in karyotyping by fluorescence in situ hybridization. Genes Chromosomes Cancer 25:241-250.
37. Rowley JD, Reshmi S, Carlson K, Roulston D. 1999. Spectral karyotype analysis of T-cell acute leukemia. Blood 93:2038-2042.
38. Sawyer JR, Lukacs JL, Munshi N, Desikan KR, Singhal S, Mehta J, Siegel D, Shaughnessy J, Barlogie B. 1998. Identification of new nonrandom translocations in multiple myeloma with multicolor spectral karyotyping. Blood 92:4269-4278.
39. Schoenberg Fejzo M, Godfrey T, Chen C, Waldman F, Gray JW. 1998. Molecular cytogenetic analysis of consistent abnormalities at 8q12-q22 in breast cancer. Genes Chromosomes Cancer 22:105-113.
40. Seigneurin D, Champelovier P, Mouchiroud G, Berthier R, Leroux D, Prenant M, McGregor J, Starck J, Morle F, Micouin C. 1987. Human chronic myeloid leukemic cell line with positive Philadelphia chromosome exhibits megakaryocytic and erythroid characteristics. Exp Hematol 15:822-832.
41. Sinclair PB, Nacheva EP, Leversha M, Telford N, Chang J, Reid A, Bench A, Champion K, Huntly B, Green AR. 2000. Large deletions at the t(9;22) breakpoint are common and may identify a poor-prognosis subgroup of patients with chronic myeloid leukemia. Blood 95:738-743.
42. Veldman T, Vignon C, Schrock E, Rowley JD, Ried T. 1997. Hidden chromosome abnormalities in haematological malignancies detected by multicolor spectral karyotyping. Nat Genet 15:406-410.
43. Zattara-Cannoni H, Dufour H, Lepidi H, Chatel C, Grisoli F, Vagner-Capodano AM. 1998. Hidden chromosome abnormalities in a primary central nervous system lymphoma detected by multicolor spectral karyotyping. Cancer Genet Cytogenet 107:98-101.